PDIA3 and amyotrophic lateral sclerosis: Despite predictions that ERp57 overexpression would extend lifespan in ALS [19], SOD1G93A and double transgenic mice showed the same survival rate (Fig. 1h and Additional file 1: Fig. S1c), suggesting that ERp57 operates as an ALS modifier at early-symptomatic stages impacting motor performance.